SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-027297
Filing Date
2020-10-05
Accepted
2020-10-05 17:00:10
Documents
1
Period of Report
2020-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 24057
  Complete submission text file 0000899243-20-027297.txt   26056
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Issuer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Reporting) CIK: 0001700449 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-38707 | Film No.: 201224284

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J6EQ 44(0)20 7290 1050
Arix Bioscience Holdings Ltd (Reporting) CIK: 0001756884 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38707 | Film No.: 201224285